Cargando…
Robust controller for artificial pancreas for patients with type-1 diabetes
PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226027/ http://dx.doi.org/10.1007/s42600-023-00285-9 |
_version_ | 1785050500763222016 |
---|---|
author | Mandal, Sharmistha Sutradhar, Ashoke |
author_facet | Mandal, Sharmistha Sutradhar, Ashoke |
author_sort | Mandal, Sharmistha |
collection | PubMed |
description | PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model of T1DM patient. METHOD: A multi-objective output feedback controller has been designed for AP system considering robustness, disturbance rejection, and transient criterion. Considering H(∞), pole-placement, and H(2) constraints, a control algorithm has been developed and has been solved using linear matrix inequality (LMI) technique. RESULT: As a testing platform of the intravenous model-based designed controller, UVa/Padova T1DM metabolic simulator has been chosen which uses subcutaneous insulin delivery method. The controller has been tested in the presence of unannounced meal disturbances. Experimental results show that the controller regulates BG level very efficiently with lesser amount of insulin and avoids hypoglycemia effect. In the presence of external noises like glucose sensor noise and insulin pump error, the robustness of the controller has been checked. The performance of the controller has been compared with compound internal model control (IMC) strategy reported earlier for same meal scenario. CONCLUSION: The designed multi-objective controller gives better performance metrices than compound IMC controller. |
format | Online Article Text |
id | pubmed-10226027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102260272023-05-30 Robust controller for artificial pancreas for patients with type-1 diabetes Mandal, Sharmistha Sutradhar, Ashoke Res. Biomed. Eng. Original Article PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model of T1DM patient. METHOD: A multi-objective output feedback controller has been designed for AP system considering robustness, disturbance rejection, and transient criterion. Considering H(∞), pole-placement, and H(2) constraints, a control algorithm has been developed and has been solved using linear matrix inequality (LMI) technique. RESULT: As a testing platform of the intravenous model-based designed controller, UVa/Padova T1DM metabolic simulator has been chosen which uses subcutaneous insulin delivery method. The controller has been tested in the presence of unannounced meal disturbances. Experimental results show that the controller regulates BG level very efficiently with lesser amount of insulin and avoids hypoglycemia effect. In the presence of external noises like glucose sensor noise and insulin pump error, the robustness of the controller has been checked. The performance of the controller has been compared with compound internal model control (IMC) strategy reported earlier for same meal scenario. CONCLUSION: The designed multi-objective controller gives better performance metrices than compound IMC controller. Springer International Publishing 2023-05-29 2023 /pmc/articles/PMC10226027/ http://dx.doi.org/10.1007/s42600-023-00285-9 Text en © The Author(s), under exclusive licence to The Brazilian Society of Biomedical Engineering 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Mandal, Sharmistha Sutradhar, Ashoke Robust controller for artificial pancreas for patients with type-1 diabetes |
title | Robust controller for artificial pancreas for patients with type-1 diabetes |
title_full | Robust controller for artificial pancreas for patients with type-1 diabetes |
title_fullStr | Robust controller for artificial pancreas for patients with type-1 diabetes |
title_full_unstemmed | Robust controller for artificial pancreas for patients with type-1 diabetes |
title_short | Robust controller for artificial pancreas for patients with type-1 diabetes |
title_sort | robust controller for artificial pancreas for patients with type-1 diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226027/ http://dx.doi.org/10.1007/s42600-023-00285-9 |
work_keys_str_mv | AT mandalsharmistha robustcontrollerforartificialpancreasforpatientswithtype1diabetes AT sutradharashoke robustcontrollerforartificialpancreasforpatientswithtype1diabetes |